68 articles
This update covers major Indian and international patent news, including litigation, innovation, and key statistics. Highlights include the Iron Man suit invention, glove patents, pharmaceutical litigation, and patent…
This update examines patent infringement rulings by the Delhi High Court, statistics from the Indian Patent Office, international patent acquisitions, and licensing settlements. It also features expert analysis…
This update highlights key events in intellectual property law, including Apple’s lawsuit against Qualcomm and Bayer’s loss in the Delhi High Court. Further, it discusses recent trademark and…
The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of…
The Lee and BDR decisions signal a shift in the landscape of compulsory licensing in India. This post examines the legal and policy developments leading to these outcomes,…
The Indian government’s plan to engage US trained patent examiners has sparked debate over efficiency and policy direction in the patent office. This post analyses the benefits, concerns,…
The Delhi High Court restrained Glenmark from manufacturing and marketing generic versions of Merck’s patented antidiabetic drugs. This case underscores key principles of Indian patent law and the…
This article analyses the evolution and practice of compulsory licensing in India, focusing on landmark cases and their effects on patent activity. It assesses whether compulsory licensing influences…
This article explores compulsory licensing in patents under Indian law, focusing on its impact on business strategies and public interest. Through case studies and legal analysis, the article…
The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access…